RNA conformational propensities determine cellular activity

Nature. 2023 May;617(7962):835-841. doi: 10.1038/s41586-023-06080-x. Epub 2023 May 17.

Abstract

Cellular processes are the product of interactions between biomolecules, which associate to form biologically active complexes1. These interactions are mediated by intermolecular contacts, which if disrupted, lead to alterations in cell physiology. Nevertheless, the formation of intermolecular contacts nearly universally requires changes in the conformations of the interacting biomolecules. As a result, binding affinity and cellular activity crucially depend both on the strength of the contacts and on the inherent propensities to form binding-competent conformational states2,3. Thus, conformational penalties are ubiquitous in biology and must be known in order to quantitatively model binding energetics for protein and nucleic acid interactions4,5. However, conceptual and technological limitations have hindered our ability to dissect and quantitatively measure how conformational propensities affect cellular activity. Here we systematically altered and determined the propensities for forming the protein-bound conformation of HIV-1 TAR RNA. These propensities quantitatively predicted the binding affinities of TAR to the RNA-binding region of the Tat protein and predicted the extent of HIV-1 Tat-dependent transactivation in cells. Our results establish the role of ensemble-based conformational propensities in cellular activity and reveal an example of a cellular process driven by an exceptionally rare and short-lived RNA conformational state.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • HIV Long Terminal Repeat* / genetics
  • HIV-1* / genetics
  • HIV-1* / metabolism
  • Nucleic Acid Conformation*
  • RNA, Viral* / chemistry
  • RNA, Viral* / genetics
  • RNA, Viral* / metabolism
  • Transcriptional Activation*
  • tat Gene Products, Human Immunodeficiency Virus* / chemistry
  • tat Gene Products, Human Immunodeficiency Virus* / metabolism

Substances

  • RNA, Viral
  • tat Gene Products, Human Immunodeficiency Virus